Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Live/Pending
FIRST EXTENSION - GRANTED
FIRST EXTENSION - GRANTED
granted
on 15 May 2024
Last Applicant/ Owned by
639 Campus Drive
New Brighton
MN
55112
Serial Number
97508353 filed on 18th Jul 2022
Registration Number
N/A
Correspondent Address
Stephen R. Baird
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
PHYRAGO
Pharmaceutical preparations, namely, protein kinase inhibitors used for the treatment of some leukemias in humans
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, protein kinase inhibitors used for the treatment of some leukemias in humans
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97508353
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 209362010100
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Nov 2024 | SOU TEAS EXTENSION RECEIVED |
| 16th May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 15th May 2024 | SOU EXTENSION 1 GRANTED |
| 15th May 2024 | SOU EXTENSION 1 FILED |
| 15th May 2024 | SOU TEAS EXTENSION RECEIVED |
| 28th Nov 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 03rd Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 03rd Oct 2023 | PUBLISHED FOR OPPOSITION |
| 13th Sep 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 25th Aug 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |